Consequences of the COVID-19 Lockdown on Health and Well-being of Patients With Parkinson Disease and Post-stroke

NCT04535297 | Completed

• 1 other identifier: 203/20
• Study Type: observational
• Target: 198
• Locations: 1 country
• Sites: 1

Brief Summary

The study aimed at describing the effects of the COVID-19 social distancing on function, health and well-being of patients with Parkinson's disease or post-stroke, and test the association between the patient activation level and these effects.An anonymous survey was distributed through social media and patient associations.Community-living patients with Parkinson's disease or post-stroke were invited to answer the survey.

Conditions

Parkinson Disease; Stroke

Outcome Measures

Primary Outcomes (2)

• Patient Activation Measure (PAM®)

  The PAM is a self-reported validated, licensed tool to measure a patient's knowledge, skills and confidence for self-management. The overall score captures the extent to which people feel engaged and confident in taking care of their health condition. It consists of 13 statements rated on a Likert scale according to agreement. Scores are divided into 4 levels, where 1 represents patients who tend to be passive and feel overwhelmed managing their own health, and 4 represents patients who have effectively adopted self-management behaviors. We used a validated licensed Hebrew and version of the PAM supplied by Insignia Health (https://www.insigniahealth.com/products/pam-survey), which holds the copyright to the questionnaire.

  1 hour

• Answers to multiple-choice questions

  participants were asked to answer 27 multiple-choice questions regarding status and change in status of mobility, mood (depression, anxiety), tiredness, social support, body weight, physical activity, rehabilitative treatments and disease symptoms

  1 hour

Interventions

exposure OTHER

Exposure to social distancing due to COVID-19

Eligibility Criteria

• Age: 18 Years+
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with PD or their caregivers, or patients post-stroke or their caregivers

You may qualify if:

• People diagnosed with Parkinson's disease or their caregivers, or people post-stroke or their caregivers
• Live in the community
• If a family member or caregiver completed the survey, we asked them to answer in reference to the patient.

You may not qualify if:

• diagnosis of COVID-19
• hospitalization in the last 3 months.

Sponsors & Collaborators

• University of Haifa: lead

Study Sites (1)

Galit Yogev-Seligmann

Haifa, Please Select..., 3498838, Israel

Location

MeSH Terms

Conditions

Parkinson Disease; Stroke

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases; Cerebrovascular Disorders; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Galit Yogev-Seligmann

  University of Haifa

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr.

Study Record Dates

• First Submitted: August 31, 2020
• First Posted: September 1, 2020
• Study Start: May 10, 2020
• Primary Completion: May 30, 2020
• Study Completion: June 30, 2020
• Last Updated: September 1, 2020

Record last verified: 2020-08

Data Sharing

• IPD Sharing: Will not share

Locations

IL (1)